iCellate Medical AB

CEO: Pelle RedareICellate Medical


Description: iCellate has developed an instrument for  sensitive, specific and universal cancer cell isolation that meets physicians’, and research scientists’ previously unmet needs. It can capture the heterogeneous, plastic and extremely rare circulating tumor cells  against a background of normal blood cells. This instrument therefore lets the scientists capture and analyse the spreading cancer cells, in flagranti, as they spread. The instrument also provides opportunities for new kinds of cancer tests such as early detection of spreading cancer using a standard blood test or monitoring tumor cell concentration during cancer treatment.

Share Button